To illuminate whether NHERF1 inhibited cervical cancer cell proliferation through Wnt pathway, CCK-8 assay was performed by treating the HeLa or CaSki cells with IWR-1-endo combined with/without knockdown of NHERF1 expression. The gene discussed is NHERF1; the disease is cervical cancer.